Corinne Barr

Business Unit Head, Oncology

Corinne joined Ipsen Canada in 2022, bringing more than 20 years of industry experience in local, regional and global leadership positions. As Head of the Oncology Business Unit, Corinne is responsible for the commercial and cross-functional strategic and operational leadership of the oncology business unit.

Before joining Ipsen, Corinne played a role in multiple brand launches across varied therapeutic areas, most recently with Dompé Canada where she was the Director of Marketing & Customer Engagement. Prior to that she worked for Eli Lilly for more than 20 years in progressive roles of leadership within the organization in the U.S., Canada and England.

Corinne holds a Master of Business Administration (MBA) degree from Michael G. DeGroote School of Business, McMaster University, Hamilton, Ontario and an Honors Bachelor of Science (BSc Hons) degree in Biology from Western University, London, Ontario.

Our mission

To improve patients’ lives

Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation and specialty care. We help patients through our expertise in oncology, neuroscience, and rare disease.

Find out more about us or see other members of our leadership team.


Products and partnerships

Our products

Our mission is to improve patients’ lives.

See our products


Access our development and commercialization teams. We take bold steps to translate your science and innovations into solutions that make a difference for patients in need.

See more on partnering

Products and partnerships

What’s happening now?

See the latest
©2020 Ipsen Biopharmaceuticals, Inc. All rights reserved. June 2020 CR-CA-000013